Leonteq Securities’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.6K Buy
31
+1
+3% +$528 ﹤0.01% 964
2026
Q2
$16.1K Buy
30
+14
+88% +$7.17K ﹤0.01% 977
2026
Q1
$8.38K Sell
16
-13
-45% -$6.21K ﹤0.01% 1082
2025
Q4
$16.9K Sell
29
-27
-48% -$13.8K ﹤0.01% 1125
2025
Q3
$25.7K Buy
+56
New +$20.9K ﹤0.01% 1008
2024
Q2
– Sell
-40
Closed -$10.7K – 1257
2024
Q1
$10.7K Buy
+40
New +$9.42K ﹤0.01% 1002
2023
Q2
– Sell
-307
Closed -$74.4K – 1276
2023
Q1
$74.4K Sell
307
-160
-34% -$43.6K ﹤0.01% 701
2022
Q4
$136K Buy
+467
New +$45.7K 0.01% 623

Other funds holding MDGL

Leonteq Securities's MDGL Position: Q3 2026 in Review

Leonteq Securities increased its Madrigal Pharmaceuticals (MDGL) stake by 3.3% in Q3 2026, buying an estimated $528 and bringing the position to 31 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Leonteq Securities first reported a position in MDGL in Q4 2022 and has held it in 8 quarters since. The position peaked at $136K in Q4 2022. 338 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Leonteq Securities held 31 shares of Madrigal Pharmaceuticals worth $15.6K as of Q3 2026.
  • Leonteq Securities bought 1 Madrigal Pharmaceuticals share in Q3 2026, an estimated $528.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #964 holding.
  • Leonteq Securities first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • Leonteq Securities's Madrigal Pharmaceuticals position peaked at $136K in Q4 2022.
  • 338 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.